Transitioning from preclinical to clinical chemopreventive assessments of lyophilized black raspberries: interim results show berries modulate markers of oxidative stress in Barrett's esophagus patients.
about
Iron behaving badly: inappropriate iron chelation as a major contributor to the aetiology of vascular and other progressive inflammatory and degenerative diseasesDiet and esophageal diseaseEffects of a topically applied bioadhesive berry gel on loss of heterozygosity indices in premalignant oral lesionsTopical application of a bioadhesive black raspberry gel modulates gene expression and reduces cyclooxygenase 2 protein in human premalignant oral lesionsBioactive compounds or metabolites from black raspberries modulate T lymphocyte proliferation, myeloid cell differentiation and Jak/STAT signaling.Dietary freeze-dried black raspberry's effect on cellular antioxidant status during reflux-induced esophagitis in rats.Chemoprevention of esophageal adenocarcinomaChemopreventive properties of black raspberries in N-nitrosomethylbenzylamine-induced rat esophageal tumorigenesis: down-regulation of cyclooxygenase-2, inducible nitric oxide synthase, and c-Jun.Anthocyanins in black raspberries prevent esophageal tumors in rats.Elevated levels of urinary 8-hydroxy-2'-deoxyguanosine and 8-isoprostane in esophageal squamous cell carcinoma.Dietary Risk Reduction Factors for the Barrett's Esophagus-Esophageal Adenocarcinoma Continuum: A Review of the Recent LiteratureDietary intake of flavonoids and oesophageal and gastric cancer: incidence and survival in the United States of America (USA)Laboratory and clinical studies of cancer chemoprevention by antioxidants in berriesDietary flavonoid intake and Barrett's esophagus in western Washington State.Cancer prevention with freeze-dried berries and berry components.Suppression of Proinflammatory and Prosurvival Biomarkers in Oral Cancer Patients Consuming a Black Raspberry Phytochemical-Rich Troche.Total and individual antioxidant intake and endometrial cancer risk: results from a population-based case-control study in New JerseyFlavonoids, Flavonoid Subclasses, and Esophageal Cancer Risk: A Meta-Analysis of Epidemiologic Studies.Anthocyanins and their role in cancer prevention.Cranberry proanthocyanidins modulate reactive oxygen species in Barrett's and esophageal adenocarcinoma cell lines.Black raspberries in cancer clinical trials: Past, present and future.Randomized phase II trial of lyophilized strawberries in patients with dysplastic precancerous lesions of the esophagus.Foodstuffs for preventing cancer: the preclinical and clinical development of berries.Fruit polyphenols, immunity and inflammation.MicroRNA alterations in Barrett's esophagus, esophageal adenocarcinoma, and esophageal adenocarcinoma cell lines following cranberry extract treatment: Insights for chemoprevention.Effects of dietary components on cancer of the digestive system.Potential Benefits of Edible Berries in the Management of Aerodigestive and Gastrointestinal Tract Cancers: Preclinical and Clinical Evidence.Berries and oxidative stress markers: an overview of human intervention studies.Rubus occidentalis: The black raspberry--its potential in the prevention of cancer.Effects of anthocyanins on the prevention and treatment of cancer.Exosomal formulation of anthocyanidins against multiple cancer types.Polyphenols delivery by polymeric materials: challenges in cancer treatment.Phenolic acids in black raspberry and in the gastrointestinal tract of pigs following ingestion of black raspberry.Black raspberries demethylate Sfrp4, a WNT pathway antagonist, in rat esophageal squamous cell papilloma.Application of a low polyphenol or low ellagitannin dietary intervention and its impact on ellagitannin metabolism in men.Berry Phenolic Antioxidants - Implications for Human Health?Antioxidant Therapy and its Effectiveness in Oxidative Stress-Mediated Disorders
P2860
Q28388335-CE8CA320-EB84-4095-A37B-86C4D4558D0FQ28391919-D7FA9B4F-14D3-4BCC-8284-6CC772ED9AB3Q33328405-7EF69F5B-2879-4E25-8D04-B5AD0DD3BD64Q33943542-08767396-CF1F-4F5F-A289-A9B77485D801Q34079557-8CC3CFF8-CD8A-423F-AADC-E555C666CB83Q34130071-EDE8C8EA-0AA1-4C98-BB06-0E0FF2145791Q34408890-3167392F-6AD6-4A83-A363-C615C06113CFQ34462544-909AE5CD-AEF0-4390-A38C-2A7EA1A33F8EQ34813865-DFA7BD5E-9808-4853-97D8-AD60C27E87D2Q35064973-BFAC27FE-582C-4A5D-B49E-EA797224D82AQ35146950-B95C1038-CF03-40EE-A38B-F9A59596C239Q35274880-D818D5C1-8E96-4A18-8D59-98EE8726D13AQ35636550-5E5EE422-4E8F-4924-AAD4-4724CBA29F30Q36054274-D5973B71-521E-4373-AF7D-9688A8006942Q36376972-573AB722-5374-442C-A723-A9D502D11AD7Q36608739-A64FEEC5-7745-4F0D-9A7E-AACEF04D6A0CQ36857247-929E5661-3455-46C1-88BA-20327FF544D4Q37045133-CFA23FFD-DECF-4041-B5A0-92C9A6C574E7Q37197566-3F4A08FC-66E4-43A1-8523-F93B7ACAFDB5Q37213021-B958ACA2-E022-4E5C-B092-1DE7DE14D8C0Q37226841-478D31A8-020F-42CE-BA71-3B05952B3277Q37368400-6AB58040-6F58-4818-9476-C0A64F3956D6Q37402700-A7D2DAE1-0B24-4205-A8EF-1FF0AE72379EQ37801019-1651754F-D22A-4431-99B5-75A4C540E134Q37978857-83E8A384-B669-4B57-A969-0F32E1013F4EQ38212849-8A7A1D15-59B0-4B72-BD48-E23AA92ECC1AQ38381476-2576B483-65B1-4EA8-88A4-2D822780504AQ38557528-1ADA343B-8098-45C4-A2DD-F62480F2E8F1Q38677844-63B81D9C-8C17-4F75-BC02-9F0EC0F40848Q38959026-F9E20039-79D2-4B78-9559-6B7B2D76B34FQ38959552-35DD8BCD-32C1-46E3-AA37-959552769496Q39117499-C57BCE0A-25F2-49A7-88A9-A5BF0A957E4BQ46130563-8CD64B88-0582-4E45-9506-ABC6F26D181EQ51438076-0B5E763F-B298-4C2B-AB31-ABD917AA4382Q53555641-AB710DFD-EE83-4E8D-B748-D7CD2BCC4236Q55022478-D0F7F237-3DCC-40F6-BB2C-51802AB82F31Q57766494-C4B93514-0EA7-493F-AD44-FA3A5D21C150
P2860
Transitioning from preclinical to clinical chemopreventive assessments of lyophilized black raspberries: interim results show berries modulate markers of oxidative stress in Barrett's esophagus patients.
description
2006 nî lūn-bûn
@nan
2006 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
Transitioning from preclinical ...... Barrett's esophagus patients.
@ast
Transitioning from preclinical ...... Barrett's esophagus patients.
@en
Transitioning from preclinical ...... Barrett's esophagus patients.
@nl
type
label
Transitioning from preclinical ...... Barrett's esophagus patients.
@ast
Transitioning from preclinical ...... Barrett's esophagus patients.
@en
Transitioning from preclinical ...... Barrett's esophagus patients.
@nl
prefLabel
Transitioning from preclinical ...... Barrett's esophagus patients.
@ast
Transitioning from preclinical ...... Barrett's esophagus patients.
@en
Transitioning from preclinical ...... Barrett's esophagus patients.
@nl
P2093
P1433
P1476
Transitioning from preclinical ...... Barrett's esophagus patients.
@en
P2093
Cynthia D Hammond
Gary D Stoner
Jennifer M Mele
John J Fromkes
Laura A Kresty
Maureen E Baird
Wendy L Frankel
P304
P356
10.1207/S15327914NC5401_15
P577
2006-01-01T00:00:00Z